FUNDAMENTALS · Fundamentals · JP Basic Materials

Daicel (4202) Fundamentals 2026 — P/E 38.1x, Revenue Analysis | SniperIQ

Daicel (4202) is a JP-listed Basic Materials company in Chemicals - Specialty with a market capitalization of ¥376.6B, trading at ¥1474.50 on the JPX. This SniperIQ fundamentals page covers Daicel's valuation (P/E 38.1x, P/B 1.1x), profitability (net margin 1.8%), revenue (¥579.6B in FY2026), balance-sheet quality, and AI signal context — from live market data, research only.

Market Cap¥376.6B
P/E (TTM)38.1x
Net Margin1.8%
Revenue (FY26)¥579.6B

Full research coverage

  • 8-Quarter Revenue & Margin Trend
  • Debt Maturity & Coverage
  • Peer Valuation Comparison
  • Free Cash Flow & Owner Earnings
  • AI Signal + Institutional Flow
  • DCF Valuation Model

Frequently Asked Questions

What is Daicel's market cap?

Daicel (4202) has a market capitalization of approximately ¥376.6B, trading at ¥1474.50 on the JPX. Market cap moves with the live share price.

What is Daicel's P/E ratio?

Daicel's trailing twelve-month P/E ratio is 38.1x, with a price-to-book (P/B) of 1.1x. Valuation multiples are best compared with Basic Materials sector peers rather than read in isolation.

How profitable is Daicel?

Daicel runs a net profit margin of 1.8%, a gross margin of 25.2%, and an operating margin of 7.3%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.

How much revenue does Daicel generate?

Daicel reported revenue of ¥579.6B for fiscal year 2026, with net income of ¥10.2B and earnings per share (EPS) of 38.74. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.

Does Daicel pay a dividend?

Daicel offers a trailing dividend yield of about 4.1%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.

Is Daicel financially healthy?

Daicel carries a debt-to-equity ratio of 0.86x and a current ratio of 2.04x, with a market beta of 0.54. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.

Is Daicel a good stock to buy in 2026?

SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Daicel (4202) the key facts are: market cap ¥376.6B, P/E 38.1x, revenue ¥579.6B, 52-week range 1112.5-1658. Weigh valuation, profitability, growth, and balance-sheet strength against Basic Materials peers and form your own view.

Track Daicel's full fundamentals live

Get Daicel's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.

Related: C.Uyemura & (4966) fundamentals · PT Bintang Mitra Semestaraya (BMSR) fundamentals · Himadri Speciality Chemical (HSCL) fundamentals · CMOC Group (3993) fundamentals · All stock fundamentals · AI signal library
Research Hubs: Fundamentals library · Screeners · Institutional positioning · Super investors · Daily signals · Platform comparisons